RT Journal Article
SR Electronic
A1 Buckley, Rita
T1 TENDER Trial 2-Year Outcomes Show Long-Term Benefits of Tocilizumab in sJIA
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 13
SP 14
OP 15
DO 10.1177/155989771113007
UL http://mdc.sagepub.com/content/11/13/14.abstract
AB This article discusses the efficacy and safety results from A Randomized, Placebo-Controlled Study to Evaluate the Effect of Tocilizumab on Disease Response in Patients With Active Systemic Juvenile Idiopathic Arthritis, With an Open-Label Extension to Examine the Long-Term Use of Tocilizumab [TENDER; NCT00642460].